MET and breast carcinoma: In order to investigate about the master role HGF/c-Met pathway could have in crosstalk between ASCs and breast cancer cells favouring tumorigenesis, we repeated co-culture experiments in vitro, inhibiting c-Met in epithelial cells by simultaneous treatment with a specific inhibitor of its kinase activity.